Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
UnitedHealth Group (UNH) earnings Q2 2026
UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as…
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…
Abivax stock soars after new data on bowel disease medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for…
Medicare will soon cover obesity drugs, but many seniors may not know
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
Eli Lilly makes a new push into vaccines — here’s what to know
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Biogen Alzheimer’s drug moves to late stage trial
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for…
Novo Nordisk releases new high-dose Wegovy data
A Wegovy injection pen shown in Waterbury, Vermont, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…